1. Home
  2. CFLT vs CORT Comparison

CFLT vs CORT Comparison

Compare CFLT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

HOLD

Current Price

$30.14

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$83.59

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFLT
CORT
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.6B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CFLT
CORT
Price
$30.14
$83.59
Analyst Decision
Buy
Buy
Analyst Count
32
6
Target Price
$29.93
$130.20
AVG Volume (30 Days)
19.3M
1.0M
Earning Date
02-10-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.87
Revenue
$1,113,149,000.00
$741,172,000.00
Revenue This Year
$22.76
$23.96
Revenue Next Year
$16.57
$43.40
P/E Ratio
N/A
$95.70
Revenue Growth
21.57
17.92
52 Week Low
$15.64
$49.00
52 Week High
$37.90
$117.33

Technical Indicators

Market Signals
Indicator
CFLT
CORT
Relative Strength Index (RSI) 77.78 53.51
Support Level $29.95 $80.38
Resistance Level $30.07 $85.34
Average True Range (ATR) 0.16 3.54
MACD 0.07 -0.38
Stochastic Oscillator 98.84 50.50

Price Performance

Historical Comparison
CFLT
CORT

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: